Improving Patient Pathways in Multiple Sclerosis
Multiple Sclerosis is a complex therapy area in terms of both diagnosis and management. Novel agents are emerging which may help facilitate patient care being managed as a partnership between primary and secondary care. This Health Agenda meeting aims to uncover the new patient pathways that are leading to cost efficiencies in managing patients with MS and also identifying where the newer drug treatments can benefit patients.
For more details and an agenda, see the Health Agenda website
No related content found.